Artivion Inc. manufactures, processes and distributes implantable human tissues and medical devices worldwide.
| Revenue (TTM) | $458.69M |
| Gross Profit (TTM) | $296.10M |
| EBITDA | $61.40M |
| Operating Margin | 5.18% |
| Return on Equity | 3.14% |
| Return on Assets | 2.84% |
| Revenue/Share (TTM) | $9.80 |
| Book Value | $9.29 |
| Price-to-Book | 2.22 |
| Price-to-Sales (TTM) | 2.18 |
| EV/Revenue | 2.621 |
| EV/EBITDA | 18.48 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 17.50% |
| Shares Outstanding | $48.54M |
| Float | $45.97M |
| % Insiders | 4.49% |
| % Institutions | 93.47% |
Volatility is currently contracting